Despite efforts to speed the process of clinical trial site initiation, the average time to initiation for Phase II and III studies is now at nearly eight months – a month longer than what was ...
An in-depth review of the federal independent dispute resolution (IDR) procedures under the No Surprises Act (NSA) for resolving surprise medical billing disputes between health plans and providers, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results